CureVac

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CureVac and other ETFs, options, and stocks.

About CVAC

CureVac BV is a clinical-stage biopharmaceutical company, which engages in developing transformative medicines based on messenger ribonucleic acid (mRNA). Its product portfolio includes clinical and preclinical candidates across multiple disease indications in prophylactic vaccines, oncology, and protein therapy. 

CEO
Franz-Werner Haas
CEOFranz-Werner Haas
Employees
884
Employees884
Headquarters
Tübingen, Baden Wuerttemberg
HeadquartersTübingen, Baden Wuerttemberg
Founded
2000
Founded2000
Employees
884
Employees884

CVAC Key Statistics

Market cap
1.41B
Market cap1.41B
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
358.25K
Average volume358.25K
High today
$7.59
High today$7.59
Low today
$6.99
Low today$6.99
Open price
$7.38
Open price$7.38
Volume
879.76K
Volume879.76K
52 Week high
$58.36
52 Week high$58.36
52 Week low
$6.99
52 Week low$6.99

Analyst ratings

44%

of 9 ratings
Buy
33.3%
Hold
44.4%
Sell
22.2%

CVAC Earnings

-$0.70
-$0.47
-$0.23
$0.00
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Estimated
per share
Estimated per share
Actual
Expected Nov 17, After Hours
ActualExpected Nov 17, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC.